ARGX vs. ICLR: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ARGX and ICLR, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
ARGX’s market capitalization of 35.46 billion USD is substantially larger than ICLR’s 10.60 billion USD, indicating a significant difference in their market valuations.
ICLR carries a higher beta at 1.23, indicating it’s more sensitive to market moves, while ARGX (beta: 0.17) exhibits greater stability.
ARGX trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, ICLR is a standard domestic listing.
| Symbol | ARGX | ICLR |
|---|---|---|
| Company Name | argenx SE | ICON Public Limited Company |
| Country | NL | IE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical - Diagnostics & Research |
| CEO | Mr. Timothy Van Hauwermeiren EMBA, M.Sc. | Dr. Steven A. Cutler MBA, Ph.D. |
| Price | 580.73 USD | 131.27 USD |
| Market Cap | 35.46 billion USD | 10.60 billion USD |
| Beta | 0.17 | 1.23 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | May 18, 2017 | May 15, 1998 |
| ADR | Yes | No |
Performance Comparison
This chart compares the performance of ARGX and ICLR over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ARGX and ICLR, please refer to the table below.
| Symbol | ARGX | ICLR |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 51.09 | 14.16 |
| Forward PEG Ratio (TTM) | 1.32 | 1.55 |
| Price-to-Sales Ratio (P/S, TTM) | 16.50 | 1.29 |
| Price-to-Book Ratio (P/B, TTM) | 7.75 | 1.13 |
| EV-to-EBITDA (TTM) | 4573.71 | 8.88 |
| EV-to-Sales (TTM) | 15.85 | 1.66 |
Dividend Comparison
Neither ARGX nor ICLR currently pays a dividend; this often suggests they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ARGX | ICLR |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section evaluates the financial strength of ARGX and ICLR. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.
- ARGX’s Interest Coverage Ratio (ICR) of -20.85 is negative. This implies its operating earnings are insufficient to meet its interest expenses, a serious situation that threatens its financial stability and capacity to honor debt commitments.
| Symbol | ARGX | ICLR |
|---|---|---|
| Current Ratio (TTM) | 7.29 | 1.27 |
| Quick Ratio (TTM) | 6.68 | 1.27 |
| Debt-to-Equity Ratio (TTM) | 0.01 | 0.37 |
| Debt-to-Asset Ratio (TTM) | 0.01 | 0.21 |
| Net Debt-to-EBITDA Ratio (TTM) | -189.75 | 1.98 |
| Interest Coverage Ratio (TTM) | -20.85 | 5.09 |